HomeRGNX • NASDAQ
add
Regenxbio Inc
Previous close
$9.18
Day range
$9.00 - $9.82
Year range
$8.54 - $28.80
Market cap
475.14M USD
Avg Volume
756.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 24.20M | -16.31% |
Operating expense | 19.46M | -16.50% |
Net income | -59.60M | 3.67% |
Net profit margin | -246.30 | -15.11% |
Earnings per share | -1.17 | 17.02% |
EBITDA | -58.12M | 4.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 255.46M | -15.38% |
Total assets | 519.11M | -18.09% |
Total liabilities | 217.70M | -19.58% |
Total equity | 301.42M | — |
Shares outstanding | 49.55M | — |
Price to book | 1.51 | — |
Return on assets | -28.52% | — |
Return on capital | -32.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -59.60M | 3.67% |
Cash from operations | -40.55M | 17.93% |
Cash from investing | 50.26M | 30.01% |
Cash from financing | -10.86M | -125.95% |
Net change in cash | -1.15M | 92.62% |
Free cash flow | -17.97M | 36.59% |
About
Founded
2008
Headquarters
Website
Employees
344
